Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study-Reference-Cited by-同舟云学术

Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study

Published:2019-11 Issue:6 Volume:5 Page:1007-1013
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Steuber T.,Jilg C.,Tennstedt P.,De Bruycker A.,Tilki D.,Decaestecker K.,Zilli T.,Jereczek-Fossa B.A.,Wetterauer U.,Grosu A.L.,Schultze-Seemann W.,Heinzer H.,Graefen M.,Morlacco A.,Karnes R.J.,Ost P.

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey;Surcel;BJU Int,2015

2. Role of hormonal treatment in prostate cancer patients with nonmetastatic disease recurrence after local curative treatment: a systematic review;van den Bergh;Eur Urol,2016

3. EAU-ESTRO-SIOG guidelines on prostate cancer. part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer;Cornford;Eur Urol,2017

4. Identification of site-specific recurrence following primary radiation therapy for prostate cancer using C-11 choline positron emission tomography/computed tomography: a nomogram for predicting extrapelvic disease;Parker;Eur Urol,2017

5. Contemporary mapping of post-prostatectomy prostate cancer relapse with 11C-choline positron emission tomography and multiparametric magnetic resonance imaging;Sobol;J Urol,2017

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy;BMC Cancer;2024-05-25

2. Oligometastatic prostate cancer: local treatment and metastasis-directed therapy;Cancer Urology;2024-05-17

3. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions;Journal of Urology;2024-04

4. ^99mTcPSMA‐radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE‐II trial;BJU International;2024-02-12

5. Salvage-Lymphadenektomie beim Prostatakarzinom;Die Urologie;2024-02-08